Evidence map›Paper›PMID 34928108›Full record

ArticlePediatric endocrinology, diabetes, and metabolism2021

Lissencephaly-pachygyria spectrum in a North Indian boy with Wolcott-Rallison syndrome due to homozygous deletion of exon 1 in the EIF2AK3 gene.

Atul Gupta, Chaithanya Reddy, Lokesh Saini, Jaivinder Yadav, Rakesh Kumar, Jayne Houghton, Sian Ellard, Devi Dayal

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Pediatric endocrinology, diabetes, and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Atul GuptaEndocrinology and Diabetes Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, India.
Chaithanya ReddyNeurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lokesh SainiNeurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Jaivinder YadavEndocrinology and Diabetes Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, India.
Rakesh KumarEndocrinology and Diabetes Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, India.
Jayne HoughtonClinical Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.
Sian EllardInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, United Kingdom.
Devi DayalEndocrinology and Diabetes Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, India.
Post Graduate Institute of Medical Education and Research · INRoyal Devon & Exeter NHS Foundation Trust · GBUniversity of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWolcott-Rallison syndrome (WRS) is a rare autosomal recessive disorder characterized by neonatal diabetes mellitus (NDM), epiphyseal dysplasia, and hepatic and renal dysfunction. Although neuro-psychological features are common in patients with WRS, malformations of cortical development (MCDs) are rarely reported. CASE PRESENTATION: A 3-month-old boy, born to non-consanguineous parents, presented with right focal seizures since two months of age and recently detected diabetes mellitus. He also had a small head and lissencephaly-pachygyria spectrum on brain imaging. Genetic testing confirmed the diagnosis of WRS by identifying a biallelic homozygous deletion of exon 1 in the EIF2AK3 gene. The child achieved reasonable glycemic control on the basal-bolus insulin regimen.

conclusionsPresentation of WRS may occur with neurological manifestations such as lissencephaly-pachygyria spectrum. Early confirmation of the genetic diagnosis of WRS by screening for pathogenic variants in the EIF2AK3 gene is important in children with NDM and associated syndromic features. Establishing the diagnosis of WRS helps in predicting the development of subsequent clinical features, guides management, and may improve patient outcomes.

Indexed as

Diabetes Mellitus, Type 1eIF-2 KinaseEpiphysesLissencephalyOsteochondrodysplasiasExonsHomozygoteHumansInfantMaleMutationSequence DeletionEIF2AK3 protein, humaneIF-2 KinaseEIF2AK3 genemalformations of cortical development.monogenic diabetesneonatal diabetes mellitusWolcott-Rallison syndrome

Identifiers

PMID34928108
PMCPMC10226343
OpenAlexW4200591063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.